Quality of Life After Routine Nasogastric Decompression After Distal Gastrectomy for Gastric Cancer Patients
Primary Purpose
Gastric Cancer
Status
Completed
Phase
Phase 3
Locations
Japan
Study Type
Interventional
Intervention
nasogastric tube
without nasogastric tube
Sponsored by
About this trial
This is an interventional treatment trial for Gastric Cancer focused on measuring distal gastrectomy, quality of life
Eligibility Criteria
Inclusion Criteria:
- on the basis of whether distal gastrectomy was anticipated at WMUH for gastric cancer.
Exclusion Criteria:
- patients who were diagnosed inadequacy for this study by a physician.
- patients without an informed consent.
Sites / Locations
- Second Department of Surgery, Wakayama Medical University
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Active Comparator
Arm Label
A
B
Arm Description
Arm A: with nasogastric tube
Arm B: without nasogastric tube
Outcomes
Primary Outcome Measures
Quality of life
Secondary Outcome Measures
complication, hematological data,
Full Information
NCT ID
NCT00738478
First Posted
August 19, 2008
Last Updated
February 17, 2009
Sponsor
Wakayama Medical University
1. Study Identification
Unique Protocol Identification Number
NCT00738478
Brief Title
Quality of Life After Routine Nasogastric Decompression After Distal Gastrectomy for Gastric Cancer Patients
Official Title
Phase III Study for the Significance of Nasogastric Decompression Tube After Curative Distal Gastrectomy for Gastric Cancer Patients
Study Type
Interventional
2. Study Status
Record Verification Date
February 2009
Overall Recruitment Status
Completed
Study Start Date
February 2006 (undefined)
Primary Completion Date
December 2008 (Actual)
Study Completion Date
December 2008 (Actual)
3. Sponsor/Collaborators
Name of the Sponsor
Wakayama Medical University
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
The aim of the study is to evaluate whether distal gastrectomy without post-operative nasogastric decompression tube is better in terms of quality of life.
Detailed Description
Nasogastric decompression tube is an intra-operative routine in most of the time to facilitate exposure of operative field during elective distal gastrectomy, however, whether it should be retained post-operatively is controversial. Nasogastric decompression tube helps to drain the gastric remnant in case there is edema around the gastrojejunostomy, ileus and delayed gastric emptying, which can theoretically relieve nausea and abdominal distension. However, nasogastric intubation could cause patients discomfort; also it has been shown that it would cause gastroesophageal reflux which may be associated with pulmonary complication.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Gastric Cancer
Keywords
distal gastrectomy, quality of life
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 3
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
180 (Actual)
8. Arms, Groups, and Interventions
Arm Title
A
Arm Type
Experimental
Arm Description
Arm A: with nasogastric tube
Arm Title
B
Arm Type
Active Comparator
Arm Description
Arm B: without nasogastric tube
Intervention Type
Device
Intervention Name(s)
nasogastric tube
Intervention Description
insertion of nasogastric tube for 2 days after operation
Intervention Type
Device
Intervention Name(s)
without nasogastric tube
Intervention Description
without nasogastric tube after operation
Primary Outcome Measure Information:
Title
Quality of life
Time Frame
seven days after operation
Secondary Outcome Measure Information:
Title
complication, hematological data,
Time Frame
the time of discharge
10. Eligibility
Sex
All
Minimum Age & Unit of Time
20 Years
Maximum Age & Unit of Time
80 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
on the basis of whether distal gastrectomy was anticipated at WMUH for gastric cancer.
Exclusion Criteria:
patients who were diagnosed inadequacy for this study by a physician.
patients without an informed consent.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Mikihito Nakamori, MD
Organizational Affiliation
Wakayama Medical University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Second Department of Surgery, Wakayama Medical University
City
Wakayama
ZIP/Postal Code
641-8510
Country
Japan
12. IPD Sharing Statement
Learn more about this trial
Quality of Life After Routine Nasogastric Decompression After Distal Gastrectomy for Gastric Cancer Patients
We'll reach out to this number within 24 hrs